No title
Cognitive decline associated with aging and neuroinflammation has been linked to gut microbiota dysbiosis and systemic inflammation, potentially mediated through the gut–brain axis. Bioactive peptides have shown potential as therapeutic candidates for neurodegenerative and neuroinflammatory disorders. While the walnut-derived peptide EVSGPGYSPN (EV-10) has demonstrated cognitive benefits, the ther
